{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1390572321607375232.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.5582/bst.2021.01421"}},{"identifier":{"@type":"PMID","@value":"34840236"}},{"identifier":{"@type":"URI","@value":"https://www.jstage.jst.go.jp/article/bst/15/6/15_2021.01421/_pdf"}},{"identifier":{"@type":"NAID","@value":"130008143846"}},{"identifier":{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2023032598"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@language":"en","@value":"Macroscopically complete excision is a beneficial strategy for selected patients with peritoneal sarcomatosis"}],"dc:language":"en","description":[{"type":"abstract","notation":[{"@language":"en","@value":"<p>The occurrence of peritoneal sarcomatosis (PS) in patients with retroperitoneal sarcoma (RPS) indicates a poor prognosis. However, the appropriate treatment modality remains unclear. This study aimed to identify its prognostic factors and further explore the role of macroscopically complete excision (CE) in the management of PS. A retrospective database was established to evaluate patients with RPS who underwent resection between January 2011 and January 2019. Univariate and multivariate survival analyses were performed to analyze the prognostic factors and identify the population that will optimally benefit from CE. This study included a total of 49 patients with PS from 211 patients with RPS, and 34 (69.4%) patients of whom with PS underwent CE successfully. The median follow-up time was 36.0 months. There were 8 patients excluded because of loss to follow-up (<i>n</i> = 4) or death from complications within 90 days postoperatively (<i>n</i> = 4). The CE group had a marginally better prognosis compared to the macroscopically incomplete excision (IE) group (median disease-specific survival: 20 months <i>vs.</i> 8 months). Multivariate survival analysis demonstrated that completeness of operation (CE <i>vs.</i> IE) was the only independent prognostic factor in PS patients (<i>P</i> = 0.042). There was no significant difference in the overall complications between the CE and IE groups (<i>P</i> = 0.205). In conclusion, completeness of macroscopical excision is an independent prognostic predictor of PS. If technically possible, CE is a feasible strategy to improve the prognosis of selected patients with PS. </p>"}],"abstractLicenseFlag":"disallow"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1410572321607375233","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000414945984"}],"foaf:name":[{"@language":"en","@value":"Li Yang"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery/ Sarcoma Center, Peking University Cancer Hospital & Institute, Beijing, China."}]},{"@id":"https://cir.nii.ac.jp/crid/1410572321607375238","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000414945985"}],"foaf:name":[{"@language":"en","@value":"Lv Ang"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery/ Sarcoma Center, Peking University Cancer Hospital & Institute, Beijing, China."}]},{"@id":"https://cir.nii.ac.jp/crid/1410572321607375237","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000414945986"}],"foaf:name":[{"@language":"en","@value":"Wu Jianhui"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery/ Sarcoma Center, Peking University Cancer Hospital & Institute, Beijing, China."}]},{"@id":"https://cir.nii.ac.jp/crid/1410572321607375235","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000414945987"}],"foaf:name":[{"@language":"en","@value":"Li Chengpeng"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery/ Sarcoma Center, Peking University Cancer Hospital & Institute, Beijing, China."}]},{"@id":"https://cir.nii.ac.jp/crid/1410572321607375236","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000414945988"}],"foaf:name":[{"@language":"en","@value":"Liu Bonan"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery/ Sarcoma Center, Peking University Cancer Hospital & Institute, Beijing, China."}]},{"@id":"https://cir.nii.ac.jp/crid/1410572321607375232","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000414945989"}],"foaf:name":[{"@language":"en","@value":"Tian Xiuyun"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery/ Sarcoma Center, Peking University Cancer Hospital & Institute, Beijing, China."}]},{"@id":"https://cir.nii.ac.jp/crid/1410572321607375234","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000414945990"}],"foaf:name":[{"@language":"en","@value":"Qiu Hui"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery/ Sarcoma Center, Peking University Cancer Hospital & Institute, Beijing, China."}]},{"@id":"https://cir.nii.ac.jp/crid/1410572321607375239","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000414945991"}],"foaf:name":[{"@language":"en","@value":"Hao Chunyi"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery/ Sarcoma Center, Peking University Cancer Hospital & Institute, Beijing, China."}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"18817815"},{"@type":"EISSN","@value":"18817823"}],"prism:publicationName":[{"@language":"en","@value":"BioScience Trends"},{"@language":"ja","@value":"BioScience Trends"},{"@language":"en","@value":"BST"}],"dc:publisher":[{"@language":"en","@value":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement"},{"@language":"ja","@value":"特定非営利活動法人 バイオ＆ソーシャル・サイエンス推進国際研究交流会"}],"prism:publicationDate":"2021-12-31","prism:volume":"15","prism:number":"6","prism:startingPage":"382","prism:endingPage":"389"},"reviewed":"false","url":[{"@id":"https://www.jstage.jst.go.jp/article/bst/15/6/15_2021.01421/_pdf"},{"@id":"https://search.jamas.or.jp/link/ui/2023032598"}],"availableAt":"2021-12-31","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=peritoneal%20sarcomatosis,%20prognostic%20factors","dc:title":"peritoneal sarcomatosis, prognostic factors"},{"@id":"https://cir.nii.ac.jp/all?q=macroscopically%20complete%20excision","dc:title":"macroscopically complete excision"},{"@id":"https://cir.nii.ac.jp/all?q=survival%20benefit","dc:title":"survival benefit"},{"@id":"https://cir.nii.ac.jp/all?q=appropriate%20patients","dc:title":"appropriate patients"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360011143498388608","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Systematic Review on the Efficacy of Multimodal Treatment of Sarcomatosis with Cytoreduction and Intraperitoneal Chemotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011143661848960","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Assessment of Optimal Selected Prognostic Factors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619685216640","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292621420723584","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Long-term survival is possible using cytoreductive surgery plus HIPEC for sarcomatosis—Case report of 2 patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574093769267072","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574093919591168","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Management of Abdominopelvic Sarcoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574096095326720","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574096231088384","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569314660352","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Multifocality in Retroperitoneal Sarcoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570040821632","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The role of surgical margin status in retroperitoneal sarcoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137046344198272","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Peritoneal Metastasis of Retroperitoneal Tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520146992896","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Technical Considerations in Surgery for Retroperitoneal Sarcomas: Position Paper from E-Surge, a Master Class in Sarcoma Surgery, and EORTC–STBSG"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520728936192","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520740546048","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Retroperitoneal and Intra-Abdominal Sarcoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470492190720","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893942162432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Patterns of spread of recurrent intraabdominal sarcoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894501452928","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Surgery for disseminated abdominal sarcoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844126991360","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"On the exact distribution of maximally selected rank statistics"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845323762944","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Should Soft Tissue Sarcomas Be Treated at High-volume Centers?"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845598693120","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Peritoneal Sarcomatosis: Is There a Subset of Patients Who May Benefit from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319118816896","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Soft‐tissue sarcoma in adults: An update on the current state of histiotype‐specific management in an era of personalized medicine"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794144401024","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Lessons Learned From the Study of 10,000 Patients With Soft Tissue Sarcoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268212196864","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG)"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268584714240","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268680582400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Classification of Surgical Complications"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268728265728","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233271118764928","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680712498688","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Infiltration characteristics and influencing factors of retroperitoneal liposarcoma: Novel evidence for extended surgery and a tumor grading system"}]}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:2009095367"},{"@type":"CROSSREF","@value":"10.5582/bst.2021.01421"},{"@type":"PUBMED","@value":"34840236"},{"@type":"CIA","@value":"130008143846"}]}